The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
There is growing evidence that extracellular vesicles (EVs), more popularly known as exosomes, are the most relevant “active ingredient” within young plasma responsible for the effects seen in young to old plasma exchange experiments (such as in heterochronous parabiosis in mice) and clinical trials (young plasma exchange in elderly patients).
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
Exosomes are tiny vesicles that act like molecular couriers, shuttling regenerative signals. New data suggests they may carry the rejuvenation magic of young blood, without needing the blood.